Blogs about: Roche
Featured Blog
Piramed/Genentech publish data on PI3K inhibitor GDC-0941
Piramed/Genentech have published research leading to the development of lead compound GDC-0941 … more →
Kinase News
Is It Really Health 'Care' Or...
— 2 comments
swfreedomlover wrote 1 day ago: Is it ‘Social Engineering‘? Seems to me that everyday there is a new “health … more →
Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer - Bazell (1998)
— 1 comment
Bonnie Green wrote 2 days ago: Bazell, R. (1998). "Her-2: The Making of Herceptin". New York: Random House. In his intere … more →
Gilead Looking Healthy for Takeover
ristikan wrote 3 days ago: Gilead Sciences remains an attractive takeover target for major drugmakers because of its promising … more →
Piramed/Genentech publish data on PI3K inhibitor GDC-0941
crimsoncanary wrote 5 days ago: Piramed/Genentech have published research leading to the development of lead compound GDC-0941 … more →
Innovation is the New Black
Jany wrote 3 weeks ago: Originally posted on Slice. About two years out of college, I’ve started attending panels and … more →
Roche wont lower Avastin price despite NICE ruling
crimsoncanary wrote 3 weeks ago: Roche have issued a statement saying it won’t lower the price for Avastin despite UK’s … more →
Innovation is the New Black
Jany wrote 3 weeks ago: Post by Jany Xu About two years out of college, I’ve started attending panels and discussions … more →
NICE recommends against Avastin, Nexavar, Sutent and Torisel for Kidney Cancer
crimsoncanary wrote 4 weeks ago: The UK’s National Institute for Health and Clinical Excellence (NICE) has made a preliminary r … more →
Roche - Prince Brushless Motor 6.5R and 7.5R
rceasy wrote 1 month ago: Roche - Prince Brushless Motor 6.5R and 7.5R 6.5R - 6800Kv3 (RPM/Volt) 7.5R - 6000Kv3 (RPM/Volt) … more →
Ore acquire tiapamil from Roche
crimsoncanary wrote 1 month ago: Ore Pharmaceuticals have acquired Ca channel antagonist tiapamil from Roche. The company plan to dev … more →
Sorafenib and Bevacizumab combination therapy increases antitumor activity
crimsoncanary wrote 1 month ago: Combining Sorafenib and Bevacizumab has been shown to increase antitumur activity in patients with a … more →
Roche in deal with MitoSciences to evaluate mitochondrial toxicity of kinase inhibitor library
crimsoncanary wrote 1 month ago: MitoSciences have announced an agreement with Roche to generate mitochondrial toxicity profi … more →
Industry News: Roche Offers 43.7 Billion for Shares in Genentech It Does Not Already Own
tomruff wrote 1 month ago: In a bold and somewhat controversial gamble, Swiss drug maker Roche announced that it offered $43.7 … more →
Tarceva as salvage treatment in NSCLC following geftinib failure
crimsoncanary wrote 1 month ago: Data publsihed in the Annals of Oncology show that Tarceva (erlotinib) salvage therapy can be an o … more →
Roche makes offer to buy out Genentech
crimsoncanary wrote 1 month ago: Roche have made an offer to buyout remaining shares of Genentech for $89.00 per share, or a total va … more →
CERA - What's the fuss all about?
— 2 comments
Craig wrote 1 month ago: Have been doing some digging on this new drug and found the following bits of information it. So tho … more →
Genentech/Roche publish synthesis of Aurora Kinase inhbitor AKI-001
crimsoncanary wrote 1 month ago: Genentech and Roche have published preclinical data on a new Aurora Kinase inhibitor AKI-001 … more →
Have your say. Start a blog.
See our free features →
An 
Experiment
